Medical Advocates
Pegylated Interferon Alfa-2a (Pegasys)
 
Hepatic Disease Main Page

New and Noteworthy
Hepatitis B
Hepatitis C
HIV
HIV/HBV
HIV/HCV

 		  
HCV Drugs   Main New/Newsworthy  Home Page
Last Update:  March 27, 2018
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
March 2018
 
HIV
 
      Journal Papers, Abstracts, and Commentaries
 
  Peginterferon α-2a for the Treatment of HIV Infection.
 Asmuth DM, Utay NS, Pollard RB.   
Expert Opin Investig Drugs. 2015 Dec 15
 Abstract

Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon
Alfa-2a in HIV-1-Monoinfected Participants: A Phase II Clinical Trial.
 Asmuth DM, Murphy RL, Rosenkranz SL, et al 
J Infect Dis. 2010 Apr 26
 Abstract

HCV Drugs   Main New/Newsworthy  Home Page

Pegylated Interferon alfa-2a
Hepatic Disease Main Page